|
Name |
Mollicellin E
|
Molecular Formula | C22H19ClO8 | |
IUPAC Name* |
8-chloro-4,9-dihydroxy-3-methoxy-1,7-dimethyl-2-(3-methylbut-2-enoyl)-6-oxobenzo[b][1,4]benzodioxepine-10-carbaldehyde
|
|
SMILES |
CC1=C2C(=C(C(=C1Cl)O)C=O)OC3=C(C(=C(C(=C3C)C(=O)C=C(C)C)OC)O)OC2=O
|
|
InChI |
InChI=1S/C22H19ClO8/c1-8(2)6-12(25)13-10(4)18-21(17(27)20(13)29-5)31-22(28)14-9(3)15(23)16(26)11(7-24)19(14)30-18/h6-7,26-27H,1-5H3
|
|
InChIKey |
JTGLZOMMRQOKBM-UHFFFAOYSA-N
|
|
Synonyms |
Mollicellin E; 68455-10-7; MOLLICELLINE E; U7PT6U11O9; CHEBI:68803; 8-chloro-4,9-dihydroxy-3-methoxy-1,7-dimethyl-2-(3-methylbut-2-enoyl)-6-oxobenzo[b][1,4]benzodioxepine-10-carbaldehyde; UNII-U7PT6U11O9; 11H-Dibenzo(b,e)(1,4)dioxepin-4-carboxaldehyde, 2-chloro-3,9-dihydroxy-8-methoxy-1,6-dimethyl-7-(3-methyl-1-oxo-2-butenyl)-11-oxo-; CHEMBL1081162; DTXSID50218572; Q27137188; 11H-DIBENZO(B,E)(1,4)DIOXEPIN-4-CARBOXALDEHYDE, 2-CHLORO-3,9-DIHYDROXY-8-METHOXY-1,6-DIMETHYL-7-(3-METHYL-1-OXO-2-BUTEN-1-YL)-11-OXO-; 13-chloro-7,14-dihydroxy-6-methoxy-4,12-dimethyl-5-(3-methylbut-2-enoyl)-10-oxo-2,9-dioxatricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,11,13-hexaene-15-carbaldehyde; 2-chloro-3,9-dihydroxy-8-methoxy-1,6-dimethyl-7-(3-methylbut-2-enoyl)-11-oxo-11H-dibenzo[b,e][1,4]dioxepine-4-carbaldehyde; 8-chloro-4,9-dihydroxy-3-methoxy-1,7-dimethyl-2-(3-methylbut-2-enoyl)-6-oxo-benzo[b][1,4]benzodioxepine-10-carbaldehyde
|
|
CAS | 68455-10-7 | |
PubChem CID | 50201 | |
ChEMBL ID | CHEMBL1081162 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 446.8 | ALogp: | 4.7 |
HBD: | 2 | HBA: | 8 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 119.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 31 | QED Weighted: | 0.218 |
Caco-2 Permeability: | -4.968 | MDCK Permeability: | 0.00001800 |
Pgp-inhibitor: | 0.12 | Pgp-substrate: | 0.002 |
Human Intestinal Absorption (HIA): | 0.692 | 20% Bioavailability (F20%): | 0.003 |
30% Bioavailability (F30%): | 0 |
Blood-Brain-Barrier Penetration (BBB): | 0.003 | Plasma Protein Binding (PPB): | 99.41% |
Volume Distribution (VD): | 0.476 | Fu: | 1.66% |
CYP1A2-inhibitor: | 0.53 | CYP1A2-substrate: | 0.78 |
CYP2C19-inhibitor: | 0.564 | CYP2C19-substrate: | 0.508 |
CYP2C9-inhibitor: | 0.881 | CYP2C9-substrate: | 0.851 |
CYP2D6-inhibitor: | 0.004 | CYP2D6-substrate: | 0.214 |
CYP3A4-inhibitor: | 0.234 | CYP3A4-substrate: | 0.198 |
Clearance (CL): | 1.174 | Half-life (T1/2): | 0.337 |
hERG Blockers: | 0.001 | Human Hepatotoxicity (H-HT): | 0.016 |
Drug-inuced Liver Injury (DILI): | 0.34 | AMES Toxicity: | 0.08 |
Rat Oral Acute Toxicity: | 0.998 | Maximum Recommended Daily Dose: | 0.955 |
Skin Sensitization: | 0.797 | Carcinogencity: | 0.705 |
Eye Corrosion: | 0.02 | Eye Irritation: | 0.951 |
Respiratory Toxicity: | 0.74 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000631 | 0.780 | D0WY9N | 0.288 | ||||
ENC005961 | 0.763 | D05QDC | 0.237 | ||||
ENC005962 | 0.653 | D04FBR | 0.234 | ||||
ENC005960 | 0.588 | D0Q0PR | 0.226 | ||||
ENC000920 | 0.573 | D0FX2Q | 0.222 | ||||
ENC002621 | 0.481 | D0B1IP | 0.216 | ||||
ENC002864 | 0.443 | D03RTK | 0.214 | ||||
ENC002620 | 0.441 | D0G3DL | 0.211 | ||||
ENC002677 | 0.426 | D01XWG | 0.209 | ||||
ENC000921 | 0.422 | D06GCK | 0.208 |